Global Non-steroidal Anti-inflammatory Drugs（NSAID） Market Insights, Forecast to 2025

Table of Contents

1 Non-steroidal Anti-inflammatory Drugs（NSAID） Market Overview

• 1.1 Product Overview and Scope of Non-steroidal Anti-inflammatory Drugs（NSAID）
• 1.2 Non-steroidal Anti-inflammatory Drugs（NSAID） Segment by Type
  • 1.2.1 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Growth Rate Comparison by Type (2021-2026)
  • 1.2.2 Aspirin
  • 1.2.3 Ibuprofen
  • 1.2.4 Naproxen
  • 1.2.5 Nabumetone
  • 1.2.6 Others
• 1.3 Non-steroidal Anti-inflammatory Drugs（NSAID） Segment by Application
  • 1.3.1 Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Comparison by Application: 2020 VS 2026
  • 1.3.2 Back Pain Treatment
  • 1.3.3 Osteoarthritis Treatment
  • 1.3.4 Others
• 1.4 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Market Size Estimates and Forecasts
  • 1.4.1 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Revenue 2015-2026
  • 1.4.2 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Sales 2015-2026
  • 1.4.3 Non-steroidal Anti-inflammatory Drugs（NSAID） Market Size by Region: 2020 Versus 2026

2 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Market Competition by Manufacturers

• 2.1 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Manufacturers (2015-2020)
• 2.2 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Revenue Share by Manufacturers (2015-2020)
• 2.3 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Average Price by Manufacturers (2015-2020)
• 2.4 Manufacturers Non-steroidal Anti-inflammatory Drugs（NSAID） Manufacturing Sites, Area Served, Product Type
• 2.5 Non-steroidal Anti-inflammatory Drugs（NSAID） Market Competitive Situation and Trends
  • 2.5.1 Non-steroidal Anti-inflammatory Drugs（NSAID） Market Concentration Rate
  • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
  • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
• 2.7 Primary Interviews with Key Non-steroidal Anti-inflammatory Drugs（NSAID） Players (Opinion Leaders)

3 Non-steroidal Anti-inflammatory Drugs（NSAID） Retrospective Market Scenario by Region

• 3.1 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Retrospective Market Scenario in Sales by Region: 2015-2020
• 3.2 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Retrospective Market Scenario in Revenue by Region: 2015-2020
• 3.3 North America Non-steroidal Anti-inflammatory Drugs（NSAID） Market Facts & Figures by Country
  • 3.3.1 North America Non-steroidal Anti-inflammatory Drugs（NSAID） Sales by Country
  • 3.3.2 North America Non-steroidal Anti-inflammatory Drugs（NSAID） Sales by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Non-steroidal Anti-inflammatory Drugs（NSAID） Market Facts & Figures by Country
  • 3.4.1 Europe Non-steroidal Anti-inflammatory Drugs（NSAID） Sales by Country
  • 3.4.2 Europe Non-steroidal Anti-inflammatory Drugs（NSAID） Sales by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Non-steroidal Anti-inflammatory Drugs（NSAID） Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs（NSAID） Sales by Region
  • 3.5.2 Asia Pacific Non-steroidal Anti-inflammatory Drugs（NSAID） Sales by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Non-steroidal Anti-inflammatory Drugs（NSAID） Market Facts & Figures by Country
  • 3.6.1 Latin America Non-steroidal Anti-inflammatory Drugs（NSAID） Sales by Country
  • 3.6.2 Latin America Non-steroidal Anti-inflammatory Drugs（NSAID） Sales by Country
  • 3.6.3 Mexico
  • 3.6.3 Brazil
  • 3.6.3 Argentina
• 3.7 Middle East and Africa Non-steroidal Anti-inflammatory Drugs（NSAID） Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Non-steroidal Anti-inflammatory Drugs（NSAID） Sales by Country
  • 3.7.2 Middle East and Africa Non-steroidal Anti-inflammatory Drugs（NSAID） Sales by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 U.A.E

4 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Historic Market Analysis by Type

• 4.1 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Type (2015-2020)
• 4.2 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Revenue Market Share by Type (2015-2020)
• 4.3 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Price Market Share by Type (2015-2020)
• 4.4 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Historic Market Analysis by Application

• 5.1 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Application (2015-2020)
• 5.2 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Revenue Market Share by Application (2015-2020)
• 5.3 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Price by Application (2015-2020)

6 Company Profiles and Key Figures in Non-steroidal Anti-inflammatory Drugs（NSAID） Business

• 6.1 Bayer
  • 6.1.1 Corporation Information
  • 6.1.2 Bayer Description, Business Overview and Total Revenue
  • 6.1.3 Bayer Non-steroidal Anti-inflammatory Drugs（NSAID） Sales, Revenue and Gross Margin (2015-2020)
  • 6.1.4 Bayer Products Offered
  • 6.1.5 Bayer Recent Development
• 6.2 Novacap
  • 6.2.1 Novacap Non-steroidal Anti-inflammatory Drugs（NSAID） Production Sites and Area Served
  • 6.2.2 Novacap Description, Business Overview and Total Revenue
  • 6.2.3 Novacap Non-steroidal Anti-inflammatory Drugs（NSAID） Sales, Revenue and Gross Margin (2015-2020)
  • 6.2.4 Novacap Products Offered
  • 6.2.5 Novacap Recent Development
• 6.3 Abbott
  • 6.3.1 Abbott Non-steroidal Anti-inflammatory Drugs（NSAID） Production Sites and Area Served
  • 6.3.2 Abbott Description, Business Overview and Total Revenue
  • 6.3.3 Abbott Non-steroidal Anti-inflammatory Drugs（NSAID） Sales, Revenue and Gross Margin (2015-2020)
  • 6.3.4 Abbott Products Offered
  • 6.3.5 Abbott Recent Development
• 6.4 Pfizer
  • 6.4.1 Pfizer Non-steroidal Anti-inflammatory Drugs（NSAID） Production Sites and Area Served
  • 6.4.2 Pfizer Description, Business Overview and Total Revenue
  • 6.4.3 Pfizer Non-steroidal Anti-inflammatory Drugs（NSAID） Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 Pfizer Products Offered
  • 6.4.5 Pfizer Recent Development
• 6.5 Geri-Care Pharmaceuticals
  • 6.5.1 Geri-Care Pharmaceuticals Non-steroidal Anti-inflammatory Drugs（NSAID） Production Sites and Area Served
  • 6.5.2 Geri-Care Pharmaceuticals Description, Business Overview and Total Revenue
  • 6.5.3 Geri-Care Pharmaceuticals Non-steroidal Anti-inflammatory Drugs（NSAID） Sales, Revenue and Gross Margin (2015-2020)
  • 6.5.4 Geri-Care Pharmaceuticals Products Offered
  • 6.5.5 Geri-Care Pharmaceuticals Recent Development
• 6.6 Perrigo Company
  • 6.6.1 Perrigo Company Non-steroidal Anti-inflammatory Drugs（NSAID） Production Sites and Area Served
  • 6.6.2 Perrigo Company Description, Business Overview and Total Revenue
  • 6.6.3 Perrigo Company Non-steroidal Anti-inflammatory Drugs（NSAID） Sales, Revenue and Gross Margin (2015-2020)
  • 6.6.4 Perrigo Company Products Offered
  • 6.6.5 Perrigo Company Recent Development
• 6.7 Kopran
  • 6.6.1 Kopran Non-steroidal Anti-inflammatory Drugs（NSAID） Production Sites and Area Served
  • 6.6.2 Kopran Description, Business Overview and Total Revenue
  • 6.6.3 Kopran Non-steroidal Anti-inflammatory Drugs（NSAID） Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 Kopran Products Offered
  • 6.7.5 Kopran Recent Development
• 6.8 Merck Sharp & Dohme
  • 6.8.1 Merck Sharp & Dohme Non-steroidal Anti-inflammatory Drugs（NSAID） Production Sites and Area Served
  • 6.8.2 Merck Sharp & Dohme Description, Business Overview and Total Revenue
  • 6.8.3 Merck Sharp & Dohme Non-steroidal Anti-inflammatory Drugs（NSAID） Sales, Revenue and Gross Margin (2015-2020)
  • 6.8.4 Merck Sharp & Dohme Products Offered
  • 6.8.5 Merck Sharp & Dohme Recent Development
• 6.9 Sun Pharmaceutical Industries
  • 6.9.1 Sun Pharmaceutical Industries Non-steroidal Anti-inflammatory Drugs（NSAID） Production Sites and Area Served
  • 6.9.2 Sun Pharmaceutical Industries Description, Business Overview and Total Revenue
  • 6.9.3 Sun Pharmaceutical Industries Non-steroidal Anti-inflammatory Drugs（NSAID） Sales, Revenue and Gross Margin (2015-2020)
  • 6.9.4 Sun Pharmaceutical Industries Products Offered
  • 6.9.5 Sun Pharmaceutical Industries Recent Development
• 6.10 Glaxo Smith Kline
  • 6.10.1 Glaxo Smith Kline Non-steroidal Anti-inflammatory Drugs（NSAID） Production Sites and Area Served
  • 6.10.2 Glaxo Smith Kline Description, Business Overview and Total Revenue
  • 6.10.3 Glaxo Smith Kline Non-steroidal Anti-inflammatory Drugs（NSAID） Sales, Revenue and Gross Margin (2015-2020)
  • 6.10.4 Glaxo Smith Kline Products Offered
  • 6.10.5 Glaxo Smith Kline Recent Development
• 6.11 Reddy Pharmaceuticals
  • 6.11.1 Reddy Pharmaceuticals Non-steroidal Anti-inflammatory Drugs（NSAID） Production Sites and Area Served
  • 6.11.2 Reddy Pharmaceuticals Non-steroidal Anti-inflammatory Drugs（NSAID） Description, Business Overview and Total Revenue
  • 6.11.3 Reddy Pharmaceuticals Non-steroidal Anti-inflammatory Drugs（NSAID） Sales, Revenue and Gross Margin (2015-2020)
  • 6.11.4 Reddy Pharmaceuticals Products Offered
  • 6.11.5 Reddy Pharmaceuticals Recent Development
• 6.12 Johnson & Johnson
  • 6.12.1 Johnson & Johnson Non-steroidal Anti-inflammatory Drugs（NSAID） Production Sites and Area Served
  • 6.12.2 Johnson & Johnson Non-steroidal Anti-inflammatory Drugs（NSAID） Description, Business Overview and Total Revenue
  • 6.12.3 Johnson & Johnson Non-steroidal Anti-inflammatory Drugs（NSAID） Sales, Revenue and Gross Margin (2015-2020)
  • 6.12.4 Johnson & Johnson Products Offered
  • 6.12.5 Johnson & Johnson Recent Development

7 Non-steroidal Anti-inflammatory Drugs（NSAID） Manufacturing Cost Analysis

• 7.1 Non-steroidal Anti-inflammatory Drugs（NSAID） Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Raw Materials Price Trend
  • 7.1.3 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Non-steroidal Anti-inflammatory Drugs（NSAID）
• 7.4 Non-steroidal Anti-inflammatory Drugs（NSAID） Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Non-steroidal Anti-inflammatory Drugs（NSAID） Distributors List
• 8.3 Non-steroidal Anti-inflammatory Drugs（NSAID） Customers

9 Market Dynamics

• 9.1 Market Trends
• 9.2 Opportunities and Drivers
• 9.3 Challenges
• 9.4 Porter's Five Forces Analysis

10 Global Market Forecast

• 10.1 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Non-steroidal Anti-inflammatory Drugs（NSAID） by Type (2021-2026)
  • 10.1.2 Global Forecasted Revenue of Non-steroidal Anti-inflammatory Drugs（NSAID） by Type (2021-2026)
• 10.2 Non-steroidal Anti-inflammatory Drugs（NSAID） Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Non-steroidal Anti-inflammatory Drugs（NSAID） by Application (2021-2026)
  • 10.2.2 Global Forecasted Revenue of Non-steroidal Anti-inflammatory Drugs（NSAID） by Application (2021-2026)
• 10.3 Non-steroidal Anti-inflammatory Drugs（NSAID） Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Non-steroidal Anti-inflammatory Drugs（NSAID） by Region (2021-2026)
  • 10.3.2 Global Forecasted Revenue of Non-steroidal Anti-inflammatory Drugs（NSAID） by Region (2021-2026)
• 10.4 North America Non-steroidal Anti-inflammatory Drugs（NSAID） Estimates and Projections (2021-2026)
• 10.5 Europe Non-steroidal Anti-inflammatory Drugs（NSAID） Estimates and Projections (2021-2026)
• 10.6 Asia Pacific Non-steroidal Anti-inflammatory Drugs（NSAID） Estimates and Projections (2021-2026)
• 10.7 Latin America Non-steroidal Anti-inflammatory Drugs（NSAID） Estimates and Projections (2021-2026)
• 10.8 Middle East and Africa Non-steroidal Anti-inflammatory Drugs（NSAID） Estimates and Projections (2021-2026)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List